Legal Representation
Attorney
Michael G. Shariff
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 2, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Jan 2, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Sep 11, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 11, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 11, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 10, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 21, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 23, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Supplements used in genetic therapy and immunotherapy therapy; Nutraceuticals used as supplements; herbal preparations used as supplements; pharmaceuticals used as supplements in genetic therapy and immunotherapy therapy
Class 042
Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy; Product development in the field of identifying immunotherapy therapy; research and development of technology in the field of immunotherapy therapy; scientific research for medical purposes in the field of immunotherapy therapy; laboratories, clinics, hospitals providing immunotherapy therapy and genetic therapy; laboratories, clinics, and hospitals using substances made by the body or in a laboratory to boost the immune system and help the body find and destroy cancer cells
Classification
International Classes
005
042